| HOME >> BIOLOGY >> TECHNOLOGY |
Gross profit 4,492 4,910 20,518 19,059
Operating expenses:
Research and development 631 645 3,072 3,894
Sales and marketing 2,009 2,030 7,670 8,827
General and administrative 2,794 2,846 11,920 14,535
Amortization and impairment
of intangible assets 371 (8) 697 27
Total operating expenses 5,805 5,513 23,359 27,283
Loss from operations (1,313) (603) (2,841) (8,224)
Interest income, net 343 454 1,566 1,988
Other expense (130) -- (101) (54)
Net loss $(1,100) $(149) $(1,376) $(6,290)
Net loss per share - basic $(0.06) $(0.01) $(0.07) $(0.34)
and diluted
Weighted average shares
outstanding:
Basic and diluted 18,916 18,791 18,845 18,761
Stock-based compensation expense is included in the above as follows:
Cost of DIS revenue $10 $17 $71 $141
Cost of Product revenue (11) 9 49 74
Research and development 15 -- 77 130
Sales and marketing 35 41 102 279
General and administrative 32 110 606 942
Digirad Corporation
Condensed Consolidated Balance Sheets(1)
(in thousands)
December 31,
2007 2006
(unaudited)
Assets
Cash and cash equivalents
'/>"/>
| SOURCE Digirad Corporation Copyright©2008 PR Newswire. All rights reserved |